1. BMO Upgrades ICON to Outperform, Citing 'Valuation Disconnect'
BMO Capital Markets has upgraded its rating on ICON plc (ICLR) to Outperform, signaling a direct challenge to the market's current pricing of the clinical research organization. The move is anchored on a perceived 'valuation disconnect,' where BMO analysts see the stock's price as failing to reflect the company's under...